Chen Ruyin, Pu Xingqun, Liu Rongrong, Dai Xiaomeng, Ye Fangfu, Zhao Chunxia, Zhao Peng, Ruan Jian, Chen Dong
Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China.
Pharmaceutics. 2023 Aug 14;15(8):2132. doi: 10.3390/pharmaceutics15082132.
Intrahepatic cholangiocarcinoma (ICC) is one of the most aggressive types of human cancers. Although paclitaxel (PTX) was proven to exert potent anti-tumor effects against ICC, the delivery of PTX is still challenging due to its hydrophobic property. Nanoparticle (NP)-based carriers have been proven to be effective drug delivery vehicles. Among their physicochemical properties, the shape of NPs plays a crucial role in their performance of cellular internalization and thus anti-tumor efficacy of loaded drugs. In this study, dumbbell-like and snowman-like dimer NPs, composed of a polylactic acid (PLA) bulb and a shellac bulb, were designed and prepared as drug nanocarriers to enhance the efficiency of cellular uptake and anti-tumor performance. PLA/shellac dimer NPs prepared through rapid solvent exchange and controlled co-precipitation are biocompatible and their shape could flexibly be tuned by adjusting the concentration ratio of shellac to PLA. Drug-loaded snowman-like PLA/shellac dimer NPs with a sharp shape exhibit the highest cellular uptake and best cell-killing ability against cancer cells in an in vitro ICC model over traditional spherical NPs and dumbbell-like dimer NPs, as proven with the measurements of flow cytometry, fluorescent confocal microscopy, and the CCK8 assay. The underlying mechanism may be attributed to the lower surface energy required for the smaller bulbs of snowman-like PLA/shellac dimer NPs to make the initial contact with the cell membrane, which facilitates the subsequent penetration through the cellular membrane. Therefore, these dimer NPs provide a versatile platform to tune the shape of NPs and develop innovative drug nanocarriers that hold great promise to enhance cellular uptake and therapeutic efficacy.
肝内胆管癌(ICC)是人类最具侵袭性的癌症类型之一。尽管紫杉醇(PTX)已被证明对ICC具有强大的抗肿瘤作用,但其疏水性使得PTX的递送仍然具有挑战性。基于纳米颗粒(NP)的载体已被证明是有效的药物递送工具。在其物理化学性质中,NP的形状在细胞内化性能以及所载药物的抗肿瘤功效方面起着关键作用。在本研究中,设计并制备了由聚乳酸(PLA)球和紫胶球组成的哑铃状和雪人状二聚体NP作为药物纳米载体,以提高细胞摄取效率和抗肿瘤性能。通过快速溶剂交换和可控共沉淀制备的PLA/紫胶二聚体NP具有生物相容性,并且其形状可以通过调节紫胶与PLA的浓度比灵活调整。与传统球形NP和哑铃状二聚体NP相比,具有尖锐形状的载药雪人状PLA/紫胶二聚体NP在体外ICC模型中对癌细胞表现出最高的细胞摄取率和最佳的细胞杀伤能力,流式细胞术、荧光共聚焦显微镜和CCK8测定结果证明了这一点。潜在机制可能归因于雪人状PLA/紫胶二聚体NP较小的球与细胞膜进行初始接触所需的表面能较低,这有利于随后穿透细胞膜。因此,这些二聚体NP提供了一个通用平台来调整NP的形状,并开发出具有巨大潜力以提高细胞摄取和治疗效果的创新药物纳米载体。